東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/06/07 | 2,488 | 2,519 | 2,469 | 2,509 | +28 | +1.1% | 104,400 |
2021/06/04 | 2,486 | 2,495 | 2,470 | 2,481 | -17 | -0.7% | 123,600 |
2021/06/03 | 2,457 | 2,513 | 2,446 | 2,498 | +68 | +2.8% | 132,200 |
2021/06/02 | 2,420 | 2,463 | 2,410 | 2,430 | +23 | +1% | 159,500 |
2021/06/01 | 2,389 | 2,407 | 2,351 | 2,407 | +38 | +1.6% | 72,600 |
2021/05/31 | 2,350 | 2,400 | 2,340 | 2,369 | +23 | +1% | 91,800 |
2021/05/28 | 2,339 | 2,350 | 2,311 | 2,346 | +31 | +1.3% | 78,400 |
2021/05/27 | 2,300 | 2,345 | 2,300 | 2,315 | -14 | -0.6% | 122,200 |
2021/05/26 | 2,315 | 2,345 | 2,292 | 2,329 | -36 | -1.5% | 106,300 |
2021/05/25 | 2,390 | 2,408 | 2,361 | 2,365 | -31 | -1.3% | 97,600 |
2021/05/24 | 2,350 | 2,405 | 2,343 | 2,396 | +26 | +1.1% | 106,600 |
2021/05/21 | 2,345 | 2,380 | 2,332 | 2,370 | +30 | +1.3% | 89,100 |
2021/05/20 | 2,300 | 2,345 | 2,292 | 2,340 | +11 | +0.5% | 89,600 |
2021/05/19 | 2,300 | 2,330 | 2,280 | 2,329 | -1 | ±0% | 91,400 |
2021/05/18 | 2,266 | 2,348 | 2,259 | 2,330 | +14 | +0.6% | 148,900 |
2021/05/17 | 2,310 | 2,335 | 2,243 | 2,316 | +84 | +3.8% | 101,400 |
2021/05/14 | 2,237 | 2,328 | 2,220 | 2,232 | +29 | +1.3% | 59,400 |
2021/05/13 | 2,195 | 2,250 | 2,186 | 2,203 | -31 | -1.4% | 50,300 |
2021/05/12 | 2,292 | 2,292 | 2,230 | 2,234 | -64 | -2.8% | 73,700 |
2021/05/11 | 2,322 | 2,347 | 2,296 | 2,298 | -24 | -1% | 70,100 |
2021/05/10 | 2,284 | 2,327 | 2,277 | 2,322 | +38 | +1.7% | 48,900 |
2021/05/07 | 2,342 | 2,342 | 2,281 | 2,284 | -48 | -2.1% | 48,700 |
2021/05/06 | 2,295 | 2,366 | 2,295 | 2,332 | +70 | +3.1% | 105,700 |
2021/04/30 | 2,217 | 2,280 | 2,207 | 2,262 | +64 | +2.9% | 121,200 |
2021/04/28 | 2,210 | 2,217 | 2,195 | 2,198 | -13 | -0.6% | 38,900 |
2021/04/27 | 2,210 | 2,227 | 2,204 | 2,211 | -13 | -0.6% | 44,400 |
2021/04/26 | 2,237 | 2,241 | 2,205 | 2,224 | -23 | -1% | 54,200 |
2021/04/23 | 2,265 | 2,286 | 2,239 | 2,247 | -12 | -0.5% | 37,000 |
2021/04/22 | 2,258 | 2,283 | 2,249 | 2,259 | +22 | +1% | 44,500 |
2021/04/21 | 2,260 | 2,260 | 2,221 | 2,237 | -41 | -1.8% | 66,700 |
2021/04/20 | 2,300 | 2,300 | 2,269 | 2,278 | -27 | -1.2% | 54,500 |
2021/04/19 | 2,351 | 2,373 | 2,304 | 2,305 | -46 | -2% | 87,900 |
2021/04/16 | 2,355 | 2,364 | 2,327 | 2,351 | -23 | -1% | 65,400 |
2021/04/15 | 2,368 | 2,386 | 2,345 | 2,374 | +7 | +0.3% | 62,400 |
2021/04/14 | 2,419 | 2,419 | 2,355 | 2,367 | +25 | +1.1% | 69,300 |
2021/04/13 | 2,364 | 2,372 | 2,338 | 2,342 | -22 | -0.9% | 64,800 |
2021/04/12 | 2,336 | 2,378 | 2,324 | 2,364 | +39 | +1.7% | 82,000 |
2021/04/09 | 2,297 | 2,358 | 2,287 | 2,325 | +70 | +3.1% | 137,700 |
2021/04/08 | 2,293 | 2,307 | 2,245 | 2,255 | -62 | -2.7% | 66,900 |
2021/04/07 | 2,300 | 2,339 | 2,292 | 2,317 | +1 | ±0% | 57,800 |
2021/04/06 | 2,392 | 2,400 | 2,313 | 2,316 | -65 | -2.7% | 74,000 |
2021/04/05 | 2,390 | 2,405 | 2,377 | 2,381 | -9 | -0.4% | 39,400 |
2021/04/02 | 2,417 | 2,417 | 2,386 | 2,390 | -13 | -0.5% | 27,300 |
2021/04/01 | 2,450 | 2,475 | 2,390 | 2,403 | -40 | -1.6% | 64,700 |
2021/03/31 | 2,439 | 2,488 | 2,415 | 2,443 | -39 | -1.6% | 109,700 |
2021/03/30 | 2,509 | 2,529 | 2,461 | 2,482 | -34 | -1.4% | 72,100 |
2021/03/29 | 2,515 | 2,537 | 2,489 | 2,516 | +38 | +1.5% | 134,900 |
2021/03/26 | 2,435 | 2,486 | 2,433 | 2,478 | +66 | +2.7% | 62,500 |
2021/03/25 | 2,446 | 2,446 | 2,400 | 2,412 | +16 | +0.7% | 84,800 |
2021/03/24 | 2,435 | 2,450 | 2,391 | 2,396 | -71 | -2.9% | 85,600 |
851~
900
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム